Objectives: The prevalence of clinical benign prostatic hyperplasia (BPH) i
s known in Western European countries and in North America, but epidemiolog
ical data are lacking for Eastern European and Balkan countries. The object
ive of this study was to determine the prevalence of BPH in this region.
Methods: We analysed the data obtained on patients with BPH reported by uro
logists from 48 hospitals in Turkey in 1996. This analysis is based on 84,
149 case files for patients aged 40 to 80 Nears and more.
Results: The overall prevalence of clinical BPH was 18.5%. The age-specific
predominance of BPH reached a maximum for the 60-69 years age-group. A maj
ority of cases of BPH were treated medically (54.7% of cases).
Conclusion: The data are discussed in the light of our current knowledge. O
ur presentation is the first report concerning the prevalence of clinical B
PH in our region, but it needs to be completed to determine the prevalence
of clinical BPH in relation to age, country and race in the Balkans and the
Middle East.